Abstract:
The aim: To assess the e!ectiveness of the gastroduodenitis prevention program we have developed in patients of retirement age with essential arterial
hypertension who participate in the «A!ordable Medicines» program.
Materials and methods: A combined (retrospective and prospective) study was conducted, in which 150 patients took part. The main group consisted of 100
patients of retirement age with essential arterial hypertension and gastroduodenitis, which arose against the background of treatment of essential arterial
hypertension. The control group consisted of 50 patients of retirement age with essential arterial hypertension without gastroduodenitis. For this category of
the population developed a program for the prevention of gastroduodenitis. To assess the e!ectiveness of this prevention program, an «incremental cost-bene"t
ratio» (ІCВR) is used.
Results: An assessment of the e!ectiveness of the gastroduodenitis prevention program we developed in patients of retirement age with essential arterial
hypertension who participate in the «A!ordable Medicines» program.
Conclusions: Identi"ed categories of patients for whom the developed prevention program is e!ective
